News
Blood Pressure Pills Pulled
August 01, 2019
The recall affects lisinopril and hydrochlorothiazide tablets, 20 mg/12.5 mg, in 500-count bottles (NDC 68180-519-02) from lot H801815 (Exp. 3/21). The bottles were distributed throughout the United States.
Lupin Pharmaceuticals voluntarily initiated the recall July 19, 2019. At press time, the FDA had not yet classified the recall.
Lisinopril and hydrochlorothiazide tablets are available with a prescription for the treatment of hypertension.
—Jolynn Tumolo